BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22319155)

  • 1. Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation.
    Nakagome S; Mano S; Kozlowski L; Bujnicki JM; Shibata H; Fukumaki Y; Kidd JR; Kidd KK; Kawamura S; Oota H
    Mol Biol Evol; 2012 Jun; 29(6):1569-85. PubMed ID: 22319155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture.
    Adeyanju O; Okou DT; Huang C; Kumar A; Sauer C; Galloway C; Prasad M; Waters J; Cutler DJ; Zwick ME; Dhere T; Kugathasan S
    Inflamm Bowel Dis; 2012 Dec; 18(12):2357-9. PubMed ID: 22447396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
    Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3.
    Zhang W; Hui KY; Gusev A; Warner N; Ng SM; Ferguson J; Choi M; Burberry A; Abraham C; Mayer L; Desnick RJ; Cardinale CJ; Hakonarson H; Waterman M; Chowers Y; Karban A; Brant SR; Silverberg MS; Gregersen PK; Katz S; Lifton RP; Zhao H; Nuñez G; Pe'er I; Peter I; Cho JH
    Genes Immun; 2013; 14(5):310-6. PubMed ID: 23615072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Rare Missense Variation of the
    Frade-Proud'Hon-Clerc S; Smol T; Frenois F; Sand O; Vaillant E; Dhennin V; Bonnefond A; Froguel P; Fumery M; Guillon-Dellac N; Gower-Rousseau C; Vasseur F
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews.
    Sugimura K; Taylor KD; Lin YC; Hang T; Wang D; Tang YM; Fischel-Ghodsian N; Targan SR; Rotter JI; Yang H
    Am J Hum Genet; 2003 Mar; 72(3):509-18. PubMed ID: 12577202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology.
    Helbig KL; Nothnagel M; Hampe J; Balschun T; Nikolaus S; Schreiber S; Franke A; Nöthlings U
    BMC Med Genet; 2012 Mar; 13():14. PubMed ID: 22416979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Crohn's disease-associated Nod2 mutations.
    Gasche C; Nemeth M; Grundtner P; Willheim-Polli C; Ferenci P; Schwarzenbacher R
    Immunogenetics; 2008 Feb; 60(2):115-20. PubMed ID: 18253730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
    Glas J; Seiderer J; Tillack C; Pfennig S; Beigel F; Jürgens M; Olszak T; Laubender RP; Weidinger M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Diegelmann J; Czamara D; Brand S
    PLoS One; 2010 Dec; 5(12):e14466. PubMed ID: 21209938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations.
    Croucher PJ; Mascheretti S; Hampe J; Huse K; Frenzel H; Stoll M; Lu T; Nikolaus S; Yang SK; Krawczak M; Kim WH; Schreiber S
    Eur J Hum Genet; 2003 Jan; 11(1):6-16. PubMed ID: 12529700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population.
    Cavanaugh JA; Adams KE; Quak EJ; Bryce ME; O'Callaghan NJ; Rodgers HJ; Magarry GR; Butler WJ; Eaden JA; Roberts-Thomson IC; Pavli P; Wilson SR; Callen DF
    Ann Hum Genet; 2003 Jan; 67(Pt 1):35-41. PubMed ID: 12556233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.
    Hume GE; Fowler EV; Doecke J; Simms LA; Huang N; Palmieri O; Griffiths LR; Florin TH; Annese V; Radford-Smith GL
    Inflamm Bowel Dis; 2008 May; 14(5):585-90. PubMed ID: 18213697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease and genetic hitchhiking at IBD5.
    Huff CD; Witherspoon DJ; Zhang Y; Gatenbee C; Denson LA; Kugathasan S; Hakonarson H; Whiting A; Davis CT; Wu W; Xing J; Watkins WS; Bamshad MJ; Bradfield JP; Bulayeva K; Simonson TS; Jorde LB; Guthery SL
    Mol Biol Evol; 2012 Jan; 29(1):101-11. PubMed ID: 21816865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
    Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
    Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
    Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E
    World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
    Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
    BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perianal Crohn's disease: predictive factors and genotype-phenotype correlations.
    Kanaan Z; Ahmad S; Bilchuk N; Vahrenhold C; Pan J; Galandiuk S
    Dig Surg; 2012; 29(2):107-14. PubMed ID: 22440928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
    Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
    Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.